SCHEINBERG DAVID A has filed 7 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 50000 shares of SELLAS Life Sciences Group, Inc. ($SLS) on January 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | SELLAS Life Sciences Group, Inc. | $SLS | SCHEINBERG DAVID A | Director | A | Common Stock | 50000 | $0.00 | 73,082.0000 | 142,442,239 | 216.62% | 0.04% |
| Jan. 10, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | SCHEINBERG DAVID A | Director | A | Common Stock | 12500 | $0.00 | 23,082.0000 | 0 | 118.13% | 0.00% |
| Jan. 10, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | SCHEINBERG DAVID A | Director | A | Stock Option (Right to Buy) | 18500 | $0.00 | 18,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | SCHEINBERG DAVID A | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | SCHEINBERG DAVID A | Director | A | Common Stock | 6000 | $0.00 | 10,582.0000 | 0 | 130.95% | 0.00% |
| Feb. 2, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | SCHEINBERG DAVID A | Director | A | Stock Option (Right to Buy) | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 2, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | SCHEINBERG DAVID A | Director | A | Common Stock | 2500 | $0.00 | 4,582.0000 | 0 | 120.08% | 0.00% |